| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 327.14B | 322.56B | 303.03B | 279.31B | 245.42B | 266.75B |
| Gross Profit | 108.71B | 109.81B | 101.96B | 90.20B | 83.95B | 117.81B |
| EBITDA | 39.60B | 44.05B | 43.18B | 34.83B | 37.85B | 37.29B |
| Net Income | 17.35B | 20.87B | 19.89B | 14.77B | 18.05B | 17.68B |
Balance Sheet | ||||||
| Total Assets | 306.13B | 319.17B | 292.16B | 239.09B | 236.60B | 238.98B |
| Cash, Cash Equivalents and Short-Term Investments | 50.14B | 56.76B | 44.30B | 32.17B | 59.00B | 73.47B |
| Total Debt | 35.88B | 36.55B | 27.04B | 1.85B | 1.98B | 6.56B |
| Total Liabilities | 95.22B | 104.10B | 91.07B | 56.41B | 53.14B | 56.24B |
| Stockholders Equity | 201.05B | 205.18B | 191.75B | 174.11B | 175.38B | 175.37B |
Cash Flow | ||||||
| Free Cash Flow | 15.18B | 10.99B | -6.84B | -7.41B | 8.81B | 19.11B |
| Operating Cash Flow | 47.21B | 39.10B | 24.35B | 19.31B | 22.33B | 30.45B |
| Investing Cash Flow | -32.59B | -28.60B | -35.31B | -20.33B | 3.64B | -32.07B |
| Financing Cash Flow | -7.57B | 2.54B | 16.85B | -20.00B | -25.17B | -7.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥80.54B | 2.99 | ― | 1.54% | 20.44% | 1199.18% | |
74 Outperform | €597.03B | 21.46 | 9.28% | 1.31% | 5.50% | 27.32% | |
70 Outperform | $376.65B | 21.40 | 8.27% | 2.03% | 5.82% | -13.40% | |
67 Neutral | ¥242.35B | 19.96 | ― | 2.09% | 3.69% | -50.13% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥356.79B | 48.87 | 2.66% | 1.64% | 8.40% | -23.50% | |
61 Neutral | ¥49.08B | 22.22 | ― | 1.18% | 3.71% | -4.44% |